Addressing practical challenges in clinical practice after the recent approvals of amyloid antibodies in Alzheimer’s disease (AD) will benefit more patients. However, generating these answers using clinical trials or real-world evidence is not practical, nor feasible.
Quantitative systems pharmacology-based exploration of relevant anti-amyloid therapy challenges in clinical practice
May 22, 2024